Search Within

Gregory J Riely

Formats
  1. Journal Article (291)
  2. Meeting Abstract (264)
  3. Book Section (16)
  4. Guidelines (14)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (599)
  2. Solid Tumor Oncology Division (599)
  3. Thoracic Oncology (599)
  4. Department of Pathology and Laboratory Medicine (260)
  5. GSK Faculty (244)
  6. Human Oncology and Pathogenesis Program (219)

More Groups

People
  1. Mark Kris (220)
  2. Marc Ladanyi (187)
  3. Helena Yu (107)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (75)

More People

Years
  1. 2025 (3)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Journal of Thoracic Oncology (112)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (31)
  5. Journal of the National Comprehensive Cancer Network (25)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (173)
  2. Elsevier Inc. (136)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (38)
  5. Harborside Press (25)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (599)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stage at diagnosis as a prognostic marker for patients with KRAS-mutant metastatic lung adenocarcinomas
    Meeting Abstract

    Yu, H. A.; Hellmann, M. D.; Sima, C. S.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) NSCLC: Subgroup analysis of the ASCEND-1 trial
    Meeting Abstract

    Tan, D. S. W.; Shaw, A. T.; Mehra, R.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes for patients with thymic carcinoma: Evaluation of Masaoka staging
    Meeting Abstract

    Litvak, A. M.; Woo, K.; Hayes, S. A.; Sima, C. S.; Huang, J.; Moreira, A. L.; Tsukazan, M. T. R.; Riely, G. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial
    Meeting Abstract

    Kim, D. W.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Emerging science and therapies in non-small-cell lung cancer: Targeting the MET pathway
    Journal Article

    Kris, M. G.; Arenberg, D. A.; Herbst, R. S.; Riely, G. J.
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and brain metastases (BM) in the ASCEND-1 trial
    Meeting Abstract

    Shaw, A.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save